Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

  • Superior shelf-life of EmeradeSubscription

    13 FEB 2017By Ivan Stockley

    Last summer, I went into anaphylactic shock after being stung by a wasp. When I had recovered, my GP said I should carry an adrenaline auto-injector pen with me and we chose the Emerade brand rather than Epipen because, in addition to having a higher and more realistic dosage (500μg) it had a 30-month shelf life compared with only 18 months for Epipen.

  • Scrap the opioid substitution serviceSubscription

    9 FEB 2017By Wai Sin Kung

    I am a locum pharmacist who has worked in pharmacies in various regions of England. In many of the pharmacies I work in, I dispense methadone or buprenorphine to substance misusers and also provide clean needle packs as requested. It is disturbing for me to see drug misusers collect their methadone or buprenorphine doses and also request needles.

  • The Pharmaceutical Journal has become out of touchSubscription

    8 FEB 2017By

    It is likely that, if this letter is ever published, I will not get to read it. The reason? Well, I am slightly embarrassed to say that, as soon as my Pharmaceutical Journal arrives, I unwrap it from its plastic envelope, have a quick flick through, then head straight to the recycling bin and, with a tinge of guilt, I unceremoniously dump it there.

  • Editing The Pharmaceutical JournalSubscription

    8 FEB 2017By Douglas Simpson, , Nicholas Wood, , , , , , , ,

    We, the undersigned, are pressing for the restoration of the post of editor for The Pharmaceutical Journal. We believe that the The Pharmaceutical Journal needs to be refocused and that the recent departure of its publisher presents an ideal opportunity to review the situation.

  • Patients’ ethical framework should take precedenceSubscription

    6 FEB 2017By

    I note there is concern over the proposed changes in the conscience clause suggested by the General Pharmaceutical Council (The Pharmaceutical Journal online, 22 December ...

  • Dispensing error law needs to be challengedSubscription

    3 FEB 2017By Nick Glassbrook

    The unfortunate case of Martin White (The Pharmaceutical Journal online, 22 December 2016) certainly has features in common with Elizabeth Lee. I remember her case particularly well because I was her solicitor.

  • Why does the government continue to show little respect to community pharmacists?Subscription

    2 FEB 2017By

    Five months after the publication of the Community Pharmacy Forward View (CPFV), I continue to be frustrated at the lack of government response to our sector’s ideas and suggestions of how community pharmacy can help alleviate some of the stress on the NHS. We have an opportunity to shape our future role as an important element of the frontline ...

  • Why there is evidence to be hopeful about neuroscience and drug developmentSubscription

    2 FEB 2017By

    We continue to see media reports describing how pharmaceutical companies are cutting or altogether halting investment in neuroscience, thereby eliminating the possibility of innovative treatments for devastating brain disorders such as depression and

  • Medicines optimisation service in Weymouth and PortlandSubscription

    1 FEB 2017By

    In September 2015, the medicines optimisation service (MOS) was set up within Weymouth and Portland, Dorset. The MOS pharmacist conducts in-depth domiciliary consultations with patients to improve adherence and prevent harm from inappropriate medicines administration or prescribing. The service targets patients aged over 75 years with polypharmacy, on admissions avoidance care plans or living in care homes.

  • Why Australia got it right with reclassifying codeine to prescription-onlySubscription

    31 JAN 2017By

    Australia’s medicines regulator made a smart decision when it recently decided that codeine products will no longer be sold over the counter (OTC) (The Pharmaceutical Journal online, 23 December 2016).

  • Countering points made in biosimilars piece

    30 JAN 2017By

    The insight article by Alan Cassels ‘Why biosimilars should be interchangeable with biologics’ (Clinical Pharmacist 2017;9:2) provides a great opportunity to clarify some key points. I would like to counter some of the points made in Cassels’ piece — criticisms he says are used to slow down or derail the use ...

  • Balancing action on antimicrobial resistance with animal welfareSubscription

    26 JAN 2017By ,

    As almost everyone in the business of caring for the health of humans and animals is acutely aware, on our current trajectory, it is estimated that antimicrobial resistance (AMR) will cause 10 million deaths annually by 2050, with many arising from simple infections following routine operations. This is why the UK government has placed antimicrobial resistance at the top of its risk register alongside terrorism and pandemic influenza.

  • Why we defend the 'conscience' clauseSubscription

    24 JAN 2017By Chik Kaw Tan, Simon Lewis, David Clapham, Esther Afetorgbor, Steven Bamford, Nicola Ward

    Christians in Pharmacy (CiP), a network of Christian pharmacists, technicians and pharmaceutical scientists, is seriously concerned with the implications of the proposals in the General Pharmaceutical Council (GPhC) consultation on religion, personal beliefs and values in pharmacy (The ...

  • The myth of the male menopauseSubscription

    20 JAN 2017By Terry Maguire

    My old friend and fellow pharmacist Sid Dajani has been making passionate pleas on your pages and elsewhere for pharmacists to identify testosterone deficiency (The Pharmaceutical Journal 2016;297:364). He is confident that, among men of a certain age, a dangerous lack of male hormone puts them at perilous ...

  • Asthma patients deserve better careSubscription

    20 JAN 2017By

    The 2016 Asthma UK annual asthma survey has produced some shocking findings. There are 5.4 million people in the UK diagnosed with asthma, but we found that two-thirds were not receiving the basic care that they need in order to stay well.

  • Why Australia decided to make all codeine products prescription onlySubscription

    19 JAN 2017By ,

    The recent decision in Australia to make codeine-containing medications prescription only from 2018 (The Pharmaceutical Journal online, 23 December 2016) was reported to have been met with disappointment from the Pharmaceutical Society of Australia.

  • My concerns with changes to the conscience clauseSubscription

    17 JAN 2017By

    I read with interest about the proposed change to the conscience clause for pharmacists (The Pharmaceutical Journal online, 22 December 2016). This concerns me.

  • Irresponsible to allow technicians to do clinical checksSubscription

    17 JAN 2017By

    The Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board, established by the Department of Health to ‘rebalance’ pharmacy legislation and regulation, is expected to meet again in late January 2017.

  • Inappropriate piece about increasing OTC salesSubscription

    16 JAN 2017By

    I am concerned about one of your recent articles, particularly the headline ‘How pharmacists can boost sales of over-the-counter (OTC) medicines’ (Pharmaceutical Journal online, 9 January 2016).

  • Criminalisation of dispensing errors continues to haunt pharmacySubscription

    13 JAN 2017By

    The suspended prison sentence passed on Northern Ireland pharmacist Martin White is deeply troubling for the pharmacy profession (Pharmaceutical Journal online, 22 December 2016).

  • Progress with rebalancing medicines legislation programme is unacceptably slowSubscription

    13 JAN 2017By

    The snail-like progress of the rebalancing medicines legislation programme continues to amaze me.

  • The challenges of managing diabetes at mealtimesSubscription

    5 JAN 2017By

    Mealtimes pose many challenges for people living with diabetes, especially those who require a fast-acting insulin treatment to cover the post-meal glucose surge.

  • Update on the FIP pictogram project to improve health literacySubscription

    4 JAN 2017By

    I would like to provide readers with an update of the International Pharmaceutical Federation (FIP) pictogram project.

  • Multidisciplinary preregistration training is the way forwardSubscription

    3 JAN 2017By , ,

    Pharmacists increasingly need to work within a multidisciplinary team, especially in light of their increased potential roles. However, there is currently no formalised training model for multidisciplinary learning (MDL) after graduation. Opportunities need to be sought for learning together through provision of placements and learning events.

  • Breast cancer prevention trumps cureSubscription

    23 DEC 2016By ,

    Breast cancer is the most prevalent female cancer and is estimated to increase by 50% by 2030 compared to the incidence in 2011. The decision by the National Institute for Health and Care Excellence (NICE), the UK health technology appraiser, to recommend the use of preventive medicines, which are known to decrease the risk of developing breast cancer, is a welcome advance in public health.

  • Former chair of RPS disciplinary committee with a second-to-none intellectSubscription

    22 DEC 2016By Edward Mallinson

    I was saddened to hear that Sir Mota Singh QC, Crown Court judge and former chair of the Royal Pharmaceutical Society of Great Britain (RPSGB) Disciplinary Committee, died on 13 November 2016, aged 86 years.

  • Be careful how you promote the NMS to patientsSubscription

    21 DEC 2016By Jessica di Gesso

    I am writing to urge community pharmacists to be mindful of how they and their staff promote the new medicine service (NMS).

  • Patients want to learn about their condition and medicinesSubscription

    20 DEC 2016By , , , ,

    The 2016 Proprietary Association Of Great Britain (PAGB) report ‘Self-care nation’ cites the public’s lack of awareness of pharmacists’ skills and expertise as the main barrier to using pharmacy as the first port of call for help to manage minor ailments (Pharmaceutical Journal 17 November 2016

  • Unanswered questions about proposed PrEP trial Subscription

    7 DEC 2016By

    With 17 new HIV diagnoses made every day in the UK, we need to be bold and ambitious in our approach to HIV prevention — and this must include access to pre-exposure prophylaxis (PrEP) for all who need it.

  • Potential pharmacy closure might benefit another pharmacistSubscription

    7 DEC 2016By

    Graham Phillips’s excellent and passionate letter about the future of his Southdown, Harpenden, Hertfordshire pharmacy (The Pharmaceutical Journal 2016;297:294) illustrates the quandary proprietor pharmacists have.

  • Salford lung study in COPD: an example of pharmacists engaged in researchSubscription

    5 DEC 2016By

    We read with interest your editorial (The Pharmaceutical Journal 2016;297:128) and comment article by Sheri L Koshman (

  • Ending stigma towards HIV is the first step towards ending AIDSSubscription

    1 DEC 2016By

    On this World AIDS Day the National AIDS Trust’s theme is stigma, and there is so much that healthcare workers can do to help to combat stigma from the frontlines. The recently published UK Stigma Index highlighted the real problem in healthcare, with only 58% of people living with HIV feeling well supported by their GP practice, and 13% having heard negative comments ...

  • Child obesity rates continue to grow in England — we need action nowSubscription

    1 DEC 2016By

    In October 2016, NHS Digital released the latest set of figures from the National Child Measurement Programme (NCMP). Another set of childhood obesity statistics and another bleak picture. Year on year, we are faced with sobering figures that reveal an increasingly worrying trend: the number of obese and overweight children in the UK is not falling and is, in fact, rising.

  • Promoting self care to reduce unnecessary GP visitsSubscription

    30 NOV 2016By

    Healthcare is changing dramatically and so are the needs of our patients. As such, GPs and our teams are changing the ways in which we are working, but we also need our patients to play their part.

  • Identifying patients with testosterone deficiency in community pharmacySubscription

    24 NOV 2016By

    Addressing men’s health is always an ongoing conundrum and not just limited to “Movember”. Beyond just addressing this health issue, it is also about saving valuable NHS resources, keeping families together for longer, reducing economic loss and improving health equality.

  • We need safe and better labelled vitamin D products on the marketSubscription

    23 NOV 2016By

    Recommended vitamin D intakes for all of us living in the UK have changed following the publication of a report from the Scientific Advisory Committee on Nutrition (SACN) on 22 July 2016. New guidelines were required because of the persisting problem relating to vitamin D deficiency: ...

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

Pharmaceutical Journal Jobs

More jobs